| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 27, 2014
MINNEAPOLIS - Feb 27, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 34th Annual Healthcare...
-
Feb 26, 2014
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 24, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J....
-
Feb 18, 2014Revenue of $4.2 Billion Grew 4% on a Constant Currency Basis; 3% as Reported
MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...
-
Jan 28, 2014Supported by Recently Presented Study Results, New Indication Expands Treatment Options for Patients with Dangerous Tear in Upper Segment of Body's Main Artery
MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for...
-
Jan 27, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...
-
Jan 27, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...
-
Jan 24, 2014Net sales up 3% (up 5%, excluding foreign exchange rate movement); Medical Devices sales up 3% (up 6%, excluding foreign exchange rate movement)
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of
-
Jan 23, 2014State-of-the-Art Innovation Center Opens in Mumbai
MUMBAI, India--(BUSINESS WIRE)--Jan. 23, 2014-- Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in...
-
Jan 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to...
-
Jan 15, 2014
DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...
-
Jan 14, 2014Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jan 13, 2014Brazil Acquisition, China Joint Venture Enable Company to Address Underserved Markets, Expand Patient Access to Care
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...
-
Jan 6, 2014
MINNEAPOLIS - Jan 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual J.P. Morgan Healthcare Conference on...
-
Jan 6, 2014
MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...
-
Dec 6, 2013
Thomson Reuters ONE via COMTEX) --Study Shows Prestige® Cervical Disc Replacement Maintained Clinical Improvements, Lower Rate of Additional Surgical Procedures Compared to ACDF MEMPHIS, TENN. -...
-
Dec 4, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Dec 4, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer...
-
Nov 19, 2013(Thomson Reuters ONE via COMTEX) --- Revenue of $4.2 Billion Grew 3.3% on a Constant Currency Basis; 2.4% as Reported
MINNEAPOLIS - Nov. 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2014, which ended October 25, 2013. The Company reported worldwide...
-
Oct 31, 2013
(Thomson Reuters ONE via COMTEX) --Presented at TCT and Published by The Lancet, Results of DUTCH PEERS Negate Notion of Class Effect with Structural Stability of 'More Flexible and Highly...
-
Oct 31, 2013
(Thomson Reuters ONE via COMTEX) --New Data Presented at TCT and Published by JAMA Affirms Excellent Safety Profile of Zotarolimus-Eluting Stents SAN FRANCISCO -- Oct. 31, 2013 -- According to...
-
Oct 30, 2013
Thomson Reuters ONE via COMTEX) --Longest-term data from the first randomized, controlled trial of renal denervation presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT)...
-
Oct 29, 2013(Thomson Reuters ONE via COMTEX) --- Trial Finds Lifesaving Technology Successfully Meets Primary and Secondary Endpoints
SAN FRANCISCO and MINNEAPOLIS - Oct. 29, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on...
-
Oct 21, 2013
Thomson Reuters ONE via COMTEX) --MEMPHIS, Tenn. - Oct. 21, 2013 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today the launch of the first procedure that allows...
-
Oct 17, 2013
(Thomson Reuters ONE via COMTEX) --Late Breaking Clinical Trial Features the First U.S. Data of Novel Self-Expanding Transcatheter Valve at Premier Interventional Cardiology Meeting Other...
-
Sep 23, 2013
Thomson Reuters ONE via COMTEX) --Long-Term Clinical Trial Results Further Emphasize Safety and Added Benefits of Medtronic Proprietary Feature MINNEAPOLIS and ORLANDO - Sept. 23, 2013 -...